about
The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statinsA Dormant Microbial Component in the Development of PreeclampsiaIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesVascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Statins: a role in infected critically ill patients?High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART)SOCS1 and SOCS3 in the control of CNS immunityImmunological aspects of the treatment of depression and schizophrenia.FRET based quantification and screening technology platform for the interactions of leukocyte function-associated antigen-1 (LFA-1) with intercellular adhesion molecule-1 (ICAM-1).Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice.Association between statin therapy and outcomes in critically ill patients: a nested cohort study.Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers.The Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART): an adaptive design phase I dose-escalation study of high-dose lovastatin in acute ischemic stroke.Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties.Attenuation of astrogliosis and modulation of endothelial growth factor receptor in lipid rafts by simvastatin after traumatic brain injury.Pharmacotherapy in the treatment of Alzheimer's disease: an updateAtorvastatin inhibits inflammatory hypernociception.Novel simvastatin inhalation formulation and characterisationDry powder formulation of simvastatin.Statins and their potential targets in multiple sclerosis therapy.If It's Not One Thing, It's Another: An Inverse Relationship of Malignancy and Atherosclerotic Disease.Protective Effects of Simvastatin Against Alendronate-Induced Gastric Mucosal Injury in Rats.Statins Inhibit Fibrillary β-Amyloid Induced Inflammation in a Model of the Human Blood Brain Barrier.Pitavastatin Differentially Modulates MicroRNA-Associated Cholesterol Transport Proteins in MacrophagesAmelioration of Renal Inflammation, Endoplasmic Reticulum Stress and Apoptosis Underlies the Protective Effect of Low Dosage of Atorvastatin in Gentamicin-Induced NephrotoxicitySimvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD.Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MIEvaluation of atorvastatin and simvastatin for treatment of multiple sclerosis.Maintenance of radiation-induced intestinal fibrosis: cellular and molecular featuresClinical review: Statins and trauma--a systematic review.Simvastatin Reduces Capsular Fibrosis around Silicone Implants.Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.Targeting inflammatory pathways in chronic lymphocytic leukemia.Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review).Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies.Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways.Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review.Systemic medication and the inflammatory cascade.Role of inflammation in HIV-1 disease progression and prognosis.
P2860
Q24684244-61C146B7-6CF5-4963-A7D4-A9729674D9AAQ28069689-6D86C98E-FEF4-4339-B14B-F9C248E7F937Q28388335-EC065634-BF85-44F0-BB5B-63A42F02579BQ30319434-0A3DA634-A4B8-4616-AC9A-ED1B9CB7A01DQ30427569-D57DB8B0-4ACE-4901-BD67-07A82900B0D6Q33621245-56B7E999-6A27-4A64-B9BF-A6D109706BA4Q33717795-15ED8BAC-9CB5-47A6-B6A5-5EA2DD34AC9EQ33721031-517CB37F-A500-4632-B71D-5EF22F415E25Q33916422-F07EED8A-9F08-48B2-A556-65933C13C8B0Q33935447-31BBF317-E2CB-4FD1-BCCC-BCEF7370591DQ33984047-1CBE14EF-D3C3-4046-8810-C532C4151648Q34024108-C39D7E6D-E119-4E40-8AA2-7F10997D26C9Q34034752-22417554-AF3D-4A7E-8373-4C09C4FD438FQ34376402-23FB1412-F668-4961-875C-1F06A126A56BQ34430212-F1769E00-3784-4C9E-A7B9-E63510FB1B16Q34481842-34FDB18F-DB1A-40D1-97F0-F273CCCBD461Q35119935-80468B8F-5CF4-414D-8DB9-0F620069F9D3Q35164779-FF00F9FD-D6C7-4506-AAFD-01F5E4FBC4D8Q35269057-11532659-6ED8-4A1E-A683-884AB453CB12Q35537898-22652C48-FEB1-4DCC-AE39-54B3B1A8B0C9Q35637017-79150847-092B-4315-B2F1-7F7B4BE5EC32Q35786941-9631E6A6-F4D4-4ED7-9F9E-9F1EB5421FABQ36054103-354AA2E7-8559-495B-90F8-DD060462CA4FQ36077687-2FF8F429-4861-4CAF-8644-347BEF0E78F3Q36160580-0C5B3406-5CDF-4847-AC90-0EEDB4C67B2BQ36243216-92918C0B-329F-47E9-8720-61175589C288Q36301394-C1405D68-7036-4018-8DE6-B798C9441474Q36817063-F808ECC9-62CE-4B46-A6A4-594825622813Q36849440-83800E87-3101-4E1F-9F77-94FFDEF7E9A7Q36998040-31E68048-BA80-4D29-833F-7353FFD8EED0Q37110500-C2A4E919-E7C1-45B5-B8D3-1415F6803542Q37329977-4F3E431D-BD26-4F2A-A9AE-E1E8F3A63D36Q37351312-2188DA26-D63B-45D1-9918-F7127EBCED22Q37652125-DC2D0514-C151-4BC7-BC5E-5AEACC114D9CQ37670027-EF7691DE-7992-4F49-8C3C-B9DCAAB65C75Q37993779-74273EA1-19FF-408C-9B43-CA92075FF88CQ38071004-41B6C4BF-4DF9-4070-9914-8B0470950F8DQ38074826-A5398681-AF86-424E-9C6B-37E91BEC15E2Q38169806-2615257D-C77F-4DD4-BD6B-40D7F323936FQ38183454-27F58F06-4EE1-4B5A-9AD5-46077AA5EEBB
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Statins as anti-inflammatory agents.
@ast
Statins as anti-inflammatory agents.
@en
Statins as anti-inflammatory agents.
@nl
type
label
Statins as anti-inflammatory agents.
@ast
Statins as anti-inflammatory agents.
@en
Statins as anti-inflammatory agents.
@nl
prefLabel
Statins as anti-inflammatory agents.
@ast
Statins as anti-inflammatory agents.
@en
Statins as anti-inflammatory agents.
@nl
P1476
Statins as anti-inflammatory agents.
@en
P2093
Gabriele Weitz-Schmidt
P304
P356
10.1016/S0165-6147(02)02077-1
P577
2002-10-01T00:00:00Z